Diffuse midline glioma (DMG)
Clinical trials for Diffuse midline glioma (DMG) explained in plain language.
Never miss a new study
Get alerted when new Diffuse midline glioma (DMG) trials appear
Sign up with your email to follow new studies for Diffuse midline glioma (DMG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Slow-Release chemo implant tackle an untreatable brain tumor?
Cure Not yet recruitingThis trial is testing whether a new formulation of the chemotherapy drug cisplatin, called LSAM-Cisplatin, can be safely infused directly into the brain tumors of children and young adults with diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG). The t…
Matched conditions: DIFFUSE MIDLINE GLIOMA (DMG)
Phase 1/2 • Sponsor: NanOlogy, LLC • Aim: Cure
Last updated Aug 20, 2026 00:00 UTC
-
New hope for deadly brain cancer? early trial launches
Disease control Not yet recruitingThis early-stage study tests a new drug called FZ-AD005 in 40 people with aggressive brain tumors (high-grade glioma) that have come back or not responded to treatment. The drug is designed to target and kill cancer cells while sparing healthy ones. The main goals are to find the…
Matched conditions: DIFFUSE MIDLINE GLIOMA (DMG)
Phase 1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC